Proxy Biomedical are attending the SAGES 2017 Meeting. The Society of American Gastrointestinal and Endoscopic Surgeons Meeting taking place from the 22nd – 25th of March 2017, in Houston, Texas. Company representatives will be available upon request to discuss how Proxy Biomedical leverages extensive materials know-how and comprehensive processing capabilities, to develop resorbable, and non-resorbable hernia repair and general surgery implantable products.
Proxy Biomedical provides design, development and manufacturing services for a full suite of hernia repair solutions including: PTFE mesh, composite mesh, resorbable mesh, and mesh for both parastomal & umbilical indications. Furthermore, the company has an FDA approved product for abdominal hernia repair, MotifMESH™ MacroPorous NW Implant. The ultra-thin monolayer, non-coated mesh, with anti-adhesive and bacterial resistant properties, is a unique hernia repair solution within the anti-adhesive mesh category.
To schedule a meeting, contact firstname.lastname@example.org.
About Proxy Biomedical Limited
Proxy Biomedical specialises in product solutions for medical implantable devices, with expertise in absorbable and non-absorbable polymeric materials. The company offers a full-service solution, from the design and development of key components, to finished devices for world leading tier-one medical device companies who seek a trusted partner to help realise their product development needs. Proxy Biomedical is quality assured to ISO 13485:2012 and FDA standards, including certification for the provision of Design Services.